Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftopidil vs Tamsulosin in Neurogenic Lower Urinary Tract Dysfunction
NCT02034604Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Dec 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naftopidil in Neurogenic Lower Urinary Tract Dysfunction (NLUTD), sponsored by Samsung Medical Center. Started Dec 2013; status: completed.
02
Drugs
naftopidil
03
Conditions
Neurogenic Lower Urinary Tract Dysfunction (NLUTD)
Beyond the preview
Go deeper on NCT02034604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034604.